CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
4.1 Overview
4.1.1 Market size and forecast
4.2 Media and Reagents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Media and Reagents Cell Line and Membrane Market by Type
4.2.4.1 Serum Market size and forecast, by region
4.2.4.2 Media Market size and forecast, by region
4.2.4.3 Reagents Market size and forecast, by region
4.3 Equipments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Equipments Cell Line and Membrane Market by Type
4.3.4.1 Biosafety Cabinets Market size and forecast, by region
4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
4.3.4.3 Incubators Market size and forecast, by region
4.3.4.4 Centrifuges Market size and forecast, by region
4.3.4.5 Bioreactors Market size and forecast, by region
4.3.4.6 Storage Equipment Market size and forecast, by region
4.3.4.7 Others Market size and forecast, by region
4.4 Accessories and Consumables
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Non Mammalian Cell Line
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
5.2.4.1 Insects Market size and forecast, by region
5.2.4.2 Amphibians Market size and forecast, by region
5.3 Mammalian Cell Line
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Recombinant cell lines
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Primary cell lines
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Hybridomas
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Continuous cell lines
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Academic and Research Institutes
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Products
8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
8.2.3 North America Market size and forecast, by Source
8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.2.4 North America Market size and forecast, by Type
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Products
8.2.6.1.2 Market size and forecast, by Source
8.2.6.1.3 Market size and forecast, by Type
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Products
8.2.6.2.2 Market size and forecast, by Source
8.2.6.2.3 Market size and forecast, by Type
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Products
8.2.6.3.2 Market size and forecast, by Source
8.2.6.3.3 Market size and forecast, by Type
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Products
8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
8.3.3 Europe Market size and forecast, by Source
8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.3.4 Europe Market size and forecast, by Type
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Products
8.3.6.1.2 Market size and forecast, by Source
8.3.6.1.3 Market size and forecast, by Type
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Products
8.3.6.2.2 Market size and forecast, by Source
8.3.6.2.3 Market size and forecast, by Type
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Products
8.3.6.3.2 Market size and forecast, by Source
8.3.6.3.3 Market size and forecast, by Type
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Products
8.3.6.4.2 Market size and forecast, by Source
8.3.6.4.3 Market size and forecast, by Type
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Products
8.3.6.5.2 Market size and forecast, by Source
8.3.6.5.3 Market size and forecast, by Type
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Products
8.3.6.6.2 Market size and forecast, by Source
8.3.6.6.3 Market size and forecast, by Type
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Products
8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Source
8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.4.4 Asia-Pacific Market size and forecast, by Type
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Products
8.4.6.1.2 Market size and forecast, by Source
8.4.6.1.3 Market size and forecast, by Type
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Products
8.4.6.2.2 Market size and forecast, by Source
8.4.6.2.3 Market size and forecast, by Type
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Products
8.4.6.3.2 Market size and forecast, by Source
8.4.6.3.3 Market size and forecast, by Type
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Products
8.4.6.4.2 Market size and forecast, by Source
8.4.6.4.3 Market size and forecast, by Type
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Products
8.4.6.5.2 Market size and forecast, by Source
8.4.6.5.3 Market size and forecast, by Type
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Products
8.4.6.6.2 Market size and forecast, by Source
8.4.6.6.3 Market size and forecast, by Type
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Products
8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
8.5.3 LAMEA Market size and forecast, by Source
8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.5.4 LAMEA Market size and forecast, by Type
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Products
8.5.6.1.2 Market size and forecast, by Source
8.5.6.1.3 Market size and forecast, by Type
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Products
8.5.6.2.2 Market size and forecast, by Source
8.5.6.2.3 Market size and forecast, by Type
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Products
8.5.6.3.2 Market size and forecast, by Source
8.5.6.3.3 Market size and forecast, by Type
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Products
8.5.6.4.2 Market size and forecast, by Source
8.5.6.4.3 Market size and forecast, by Type
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Advanced Instruments LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 AGC Biologics
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cytiva Lifesciences
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Sartorius
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Cellgenix Gmbh
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Premas Biotech
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Selexis SA
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Samsung Biologics
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Lonza
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermofisher Scientific Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 PromoCell
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 ProBioGen
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
